Right ventricular failure and functional tricuspid regurgitation are associated with left-sided heart disease and pulmonary hypertension, which contribute significantly to morbidity and mortality in patients. Establishing a chronic ovine model to study right ventricular failure and functional tricuspid regurgitation will help in understanding their mechanisms, progression, and possible treatments.
The pathophysiology of severe functional tricuspid regurgitation (FTR) associated with right ventricular dysfunction is poorly understood, leading to suboptimal clinical results. We set out to establish a chronic ovine model of FTR and right heart failure to investigate the mechanisms of FTR. Twenty adult male sheep (6-12 months old, 62 ± 7 kg) underwent a left thoracotomy and baseline echocardiography. A pulmonary artery band (PAB) was placed and cinched around the main pulmonary artery (PA) to at least double the systolic pulmonary artery pressure (SPAP), inducing right ventricular (RV) pressure overload and signs of RV dilatation. PAB acutely increased the SPAP from 21 ± 2 mmHg to 62 ± 2 mmHg. The animals were followed for 8 weeks, symptoms of heart failure were treated with diuretics, and surveillance echocardiography was used to assess for pleural and abdominal fluid collection. Three animals died during the follow-up period due to stroke, hemorrhage, and acute heart failure. After 2 months, a median sternotomy and epicardial echocardiography were performed. Of the surviving 17 animals, 3 developed mild tricuspid regurgitation, 3 developed moderate tricuspid regurgitation, and 11 developed severe tricuspid regurgitation. Eight weeks of pulmonary artery banding resulted in a stable chronic ovine model of right ventricular dysfunction and significant FTR. This large animal platform can be used to further investigate the structural and molecular basis of RV failure and functional tricuspid regurgitation.
Right ventricular failure (RVF) is recognized as an important factor contributing to the morbidity and mortality of cardiac patients. The most common causes of RVF are left-sided heart disease and pulmonary hypertension1. During the progression of RVF, functional tricuspid regurgitation (FTR) may arise as a consequence of right ventricular (RV) dysfunction, annular dilatation, and subvalvular remodeling. Moderate to severe FTR is an independent predictor of mortality2,3, and it is estimated that 80%-90% of tricuspid regurgitation cases are functional in nature4. FTR itself may promote adverse ventricular remodeling by influencing either afterload or preload5. The tricuspid valve has historically been considered the forgotten valve6, and it was believed that the treatment of left-sided heart disease would resolve the associated RV pathology and FTR7. Recent data have shown this to be a faulty strategy, and current clinical guidelines advocate a much more aggressive approach to FTR4. However, the pathophysiology of severe FTR associated with right ventricular dysfunction is still poorly understood, leading to suboptimal clinical results8. The currently available large animal models of RVF are based on pressure, volume, or mixed overload. We have previously described a large animal model of RVF and TR but only in an acute setting9.
The current study focuses on a chronic ovine model of pulmonary artery banding (PAB) to increase RV afterload (pressure overload) and induce RV dysfunction and FTR. The afterload model is reliable and reproducible compared to pulmonary hypertension models, in which changes in microvasculature are less predictable and more likely10. The goal of the study was to develop a chronic large animal model of RVF and FTR that would most accurately mimic RV pressure overload in patients with left-sided heart disease and pulmonary hypertension. The establishment of such a model would permit in-depth studies on the pathophysiology of the ventricular and valvular remodeling associated with RV dysfunction and tricuspid insufficiency. The ovine model was chosen based on our prior work on the mitral valve and the published literature supporting the anatomical and physiological similarities between human and ovine hearts11,12,13.
For this study, 20 adult sheep (62 ± 7 kg) underwent a left thoracotomy and main pulmonary artery banding (PAB) to at least double the systolic pulmonary artery pressure (SPAP), thus inducing RV pressure overload. The animals were followed for 8 weeks, and the symptoms of heart failure were treated with diuretics when clinically apparent. Surveillance echocardiography was performed periodically to assess RV function and valvular competence. Following the completion of the experimental protocol for model development (8 weeks), the animals were taken back to the operating room for median sternotomy and the implantation of sonomicrometry crystals on the epicardial and intra-cardiac structures. This procedure was performed using cardiopulmonary bypass with the heart beating and with bicaval control. There were no problems in weaning the animals from the cardiopulmonary bypass or acquiring the sonomicrometry data in a stable steady-state hemodynamic environment without the need for inotropes for right heart support. We anticipate performing tricuspid ring annuloplasty and other right heart procedures in the near future using a right thoracotomy approach in both terminal and survival experiments. The current experience leads us to believe that it will be possible to wean the animals from the cardiopulmonary bypass without difficulty and that long-term survival is feasible. As such, we believe the model will permit the performance of clinically pertinent cardiac procedures. Below is a description of the steps (perioperative and operative) performed for carrying out the ovine experimental protocol.
The protocol was approved by the Michigan State University Institutional Animal Care and Use Committee (IACUC) (Protocol 2020-035, approved on 7/27/2020). For this study, 20 adult male sheep weighing 62 ± 7 kg were used.
1. Preoperative steps
2. Surgery steps
Following the completion of the experimental protocol for model development (nearly 8 weeks), the animals were taken back to the operating room for median sternotomy and the implantation of sonomicrometry crystals on the epicardial and intra-cardiac structures. This procedure was performed using cardiopulmonary bypass with the heart beating and with bicaval control, as described by our group in detail previously9. There were no problems in weaning the animals from the cardiopulmonary bypass or acquiring the sonomicrometry data in a stable steady-state hemodynamic environment.
Pulmonary artery banding acutely increased the SPAP from 21 ± 2 mmHg to 62 ± 9 mmHg (p = 0.001). Three animals died during the follow-up period due to stroke, hemorrhage, and acute heart failure. Of the surviving 17 animals, 3 developed mild TR, 3 developed moderate TR, and 11 developed severe TR. The mean TR grade (0-4; 0 = none or trace, 1 = mild, 2 = moderate, 3 = moderately severe, and 4 = severe) after the follow-up period increased from 0.8 ± 0.4 to 3.2 ± 1.2 (p = 0.0001). The presented data in Table 1 demonstrate signs of evolving right ventricular failure and the development of significant TR after 8 weeks of pulmonary banding, consistent with the echocardiographic examination of a representative animal shown in Figure 3.
Figure 1: Sheep chair. The sheep chair greatly facilitates animal imaging and the induction of anesthesia, as well as the placement of intravenous lines. It is customarily used in wool shearing, and animals are usually familiar with this position and remain quite docile for the necessary procedures. Please click here to view a larger version of this figure.
Figure 2: Intraoperative view of pulmonary artery banding. The photograph illustrates the pulmonary artery band formed by an umbilical tape passed around the main pulmonary artery, with surgical clips used to tighten and secure the band in place. The yellow arrow points to the clips applied to the umbilical cord. Abbreviations: MPA = main pulmonary artery; PAB = pulmonary artery band. Please click here to view a larger version of this figure.
Figure 3: Intraoperative echocardiographic images at 8 weeks after PAB (A = four-chamber view, B = four-chamber view with a color doppler showing FTR). Please click here to view a larger version of this figure.
Baseline | 8-weeks | |
HR (b/min) | 107±15 | 88±11 |
LVEF (%) | 62±3 | 58±4* |
SPAP mmHg | 62±2 | 40±7* |
RVFAC (%) | 50±14 | 38±7* |
TAPSE | 1.2±0.1 | 0.8±0.1* |
TR grade (0-4) | 0.4±0.5 | 3.2±1.2* |
TV annulus (cm) | 2.4±0.2 | 3.1±0.2* |
Table 1: Echocardiographic and hemodynamic data. Abbreviations: HR = heart rate; LVEF = left ventricular ejection fraction; SPAP = systolic pulmonary artery pressure; RVFAC = right ventricle fractional area change; TAPSE = tricuspid annular plane systolic excursion; TR = tricuspid regurgitation (grade 0-4); TV = tricuspid valve. The data show mean ± SD; *p < 0.05 versus baseline by a paired t-test.
In this model, 8 weeks of pulmonary artery banding resulted in a stable chronic ovine model of right ventricular dysfunction and, in most cases, significant FTR. The strengths of the presented chronic PAB model include the precise afterload adjustment during the procedure, although its influence on RV responses may differ. The model is suitable for evaluating varying degrees of RV failure or FTR, with the severity modulated by the degree of pulmonary artery constriction. Moreover, the application of fixed and stable resistance at the level of the main PA, unlike in pulmonary hypertension models, rules out the influence of changes in the pulmonary vascular bed on the afterload11. Ovine models of pulmonary hypertension with pulmonary artery embolization have not been demonstrated to predictably induce RVF14. However, it may be challenging to adequately tighten the band to achieve the desired degree (phenotype) of right heart failure15, not to mention the exact TR grade. This is reflected in the study, as similar peak PA pressure was achieved in all the animals (62 ± 9 mmHg), but it did not show any correlation with either TR or RHF. This may suggest biological variability in the remodeling responses of the strained RV to increased afterload. Nevertheless, in most cases, significant TR developed as a consequence of increased afterload and the subsequent changes related to RV remodeling and failure.
This ovine model was specifically designed to induce functional tricuspid regurgitation and differs from other models that are mainly focused on right heart dysfunction. The available models of TR are based mostly on structural damage to the TV and subvalvular apparatus16,17, thus meaning these are mostly volume overload models of RHF that do not represent the true nature of FTR. We have previously developed a model of tachycardia-induced cardiomyopathy18, which results in biventricular failure and functional mitral and tricuspid regurgitation. The current model permits the study and treatment of FTR in the case of isolated RV dysfunction. Recently, a model of gradual pulmonary artery banding with an inflatable band and a subcutaneous port has been introduced19, which may offer an extension of this technique. A catheter-based narrowing of the pulmonary artery has not yet been described, but such experimental techniques are surely on the horizon.
There are several critical steps while executing this protocol. Care must be taken while opening the fourth intercostal space so as not to injure the left internal mammary artery, which is used to establish an arterial line. The next critical step is freeing the MPA from the ascending aorta next to the left atrial appendage and passing an umbilical cord around the MPA. It is of utmost importance that, during pulmonary artery cinching, the tightness of the band is adjusted correctly, as over-tightening will result in early animal demise, while a band that is too loose will not induce an adequate degree of right heart failure and FTR. The band is progressively tightened with the successive application of a clip applier until the systemic blood pressure begins to steadily decline. It is crucial to be adept at removing the last clip expeditiously so as to avoid hemodynamic collapse and ventricular fibrillation. Emergency cardiac drugs should be on hand and easily available.
The model is limited by requiring open thoracotomy and direct surgical manipulation of the pulmonary artery, which represents a surgical risk and leads to the formation of adhesions that make subsequent surgeries more difficult. Furthermore, using the above-presented protocol, some animals experience a rapid evolution of heart failure and functional TR that is not compatible with 8 week survival. As such, an attrition rate of 15%-20% can be expected. The technique can be modified based on the scientific question at hand. In the current study, the goal of the experiment was to induce significant functional tricuspid regurgitation, and as such, aggressive pulmonary banding was used. However, the model may be modified to study the effects of various degrees of ventricular afterload (a surrogate for pulmonary hypertension) on right ventricular function and remodeling. In such scenarios, the pulmonary banding may be adjusted to achieve several different levels of pulmonary artery pressure to permit the study of the effects of different afterload levels. Additionally, the same model may be translated to rodents20 or be used in a graded fashion in sheep using an inflatable pulmonary band and subcutaneous injection port21.
The technique may be used in the future to study the mechanisms of functional tricuspid regurgitation with its associated right ventricular, annular, and subvalvular remodeling, as well as tissue changes. The model lends itself to the study of reverse remodeling as the pulmonary band is reversible through a repeat thoracotomy. Furthermore, this model has already been used to study right ventricular mechanical assist devices21, and it is anticipated that it will be harnessed more frequently as the field of right-sided mechanical support continues to evolve.
In conclusion, the presented large animal model of right heart failure and functional tricuspid valve regurgitation is reproducible and effective for producing FTR with a relatively low attrition rate. This large animal platform can be used to further investigate the structural and molecular basis of RV failure and functional tricuspid regurgitation. This model may also facilitate the evaluation of interventions targeting the failing RV and the TV apparatus.
The authors have nothing to disclose.
The study was funded by an internal grant from the Meijer Heart and Vascular Institute at Spectrum Health.
Anesthesia Machine Drager Narkomed MRI-2 | Drager | 4116091-001 | |
angiocatheter | BD | BD382268 | 14GAx8.25cm |
BD ChloraPrep Scrub Teal 26 ml applicator with a sterile solution | |||
Blade #11 | Bard-Parker | 371111 | |
Buprenorphine | HIKMA | ||
cefazolin 1.0g | Hikma | 0143-9924-90 | |
Diprivan 200mg/20ml | 63323-0269-29 | FRESENIUS KABI | |
Electrosurgical generator Valleylab Force FX | Valleylab | CF5L44233A | |
Gentamicin Sulfate 40 mg / mL | Fresenius | 406365 | |
i-Stat Blood analyzer MN 300 | Abbott | ||
Lidocaine HCl 1% | Pfizer | 243243 | |
Open ligating clip appliers Horizon Medium | Teleflex | 237061 | |
PERMAHAND Silk Suture | PERMA HAND | SA 63H | |
Pinnacle Introducer sheath | Terrumo | RSS102 | sheath length 10cm |
Prolene 3-0 | ETHICON | 8684H | |
Titanium Clips Medium | Teleflex | 2200 | |
Umbilical tape | Ethicon | EFA 1165 | |
VICRYL 2 coated undyed 1X54" TP-1 | ETHICON | J 880T | |
Vicryl 2-0 | ETHICON | J269H |